Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerclage Pessary vs Progesterone for High-risk Preterm Pregnancy
NCT03637062Not yet recruiting
- Sponsor
- QH Medical
- Start
- Dec 2024
- Primary completion
- Dec 2026
01
Overview
Randomised, open-label trial (2 arms), sponsored by QH Medical. Primary endpoint: Child's birth and survival rate at 34 weeks. Planned start Dec 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT03637062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03637062.